Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > News > Companies enter deals to test drugs for diseases in the brain

December 3rd, 2003

Companies enter deals to test drugs for diseases in the brain

Abstract:
Designing therapeutic drugs to treat degenerative diseases such as Alzheimer’s and Lou Gehrig’s is challenging enough. But getting them past the protective blood-brain barrier and into brain tissue can prove mind-boggling.
Two biotechnology companies that specialize in nanoscale pharmaceuticals signed deals recently that may allow them to accomplish both feats. Advectus Life Sciences Inc. in Vancouver and C Sixty Inc. in Houston announced partnerships that could pave the way for therapies for Alzheimer’s, Lou Gehrig’s disease and other life-threatening conditions.

Source:
SmallTimes

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic